Viracta Therapeutics Inc【VIRX】株式ニュース

個人投資家向けのプロ仕様のツール。

プレミアム

Form 8-K - Current report

Viracta Therapeutics Announces Wind Down of Operations

SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage...

Form 8-K - Current report

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

- Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or...

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage...

Form 4 - Statement of changes in beneficial ownership of securities

Renee 1月前

Yoiks....that was an important zeeeeero. Glad you caught it,

👍️0

trader59 1月前

Left out a zero...
$.0678

👍️0

Renee 1月前

VIRX: Delisted from the Nasdaq to the OTC. ***pps dropped 55% from ~.15 to .678 on 9+ million volume.

https://otce.finra.org/otce/dailyList?viewType=Additions

👍️0

glenn1919 3月前

VIRX.................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783

👍️0

Invest-in-America 3月前

VIRX: Up 35% in the Post-M today. (28-Mil. Float)

👍️0

TrendTrade2016 4月前

VIRX DILUTION HITTING HARD

VIRX..............................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783

👍️0

Awl416 7月前

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

👍️0

glenn1919 11月前

VIRX......................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783

The Night Stalker 2年前

https://stockcharts.com/h-sc/ui?s=virx&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

👍️0

The Night Stalker 2年前

nice

👍️0

The Night Stalker 2年前

lil dip

👍️0

The Night Stalker 2年前

soon

👍️0

The Night Stalker 2年前

https://www.barchart.com/stocks/quotes/VIRX/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=VIRX&grid=1&height=500&studyheight=100

👍️0

The Night Stalker 2年前

rip

👍️0

The Night Stalker 2年前

reasy

👍️0

The Night Stalker 2年前

nice

👍️0

The Night Stalker 2年前

dip

👍️0

The Night Stalker 2年前

dip

👍️0

The Night Stalker 2年前

nice

👍️0

The Night Stalker 2年前

ready

👍️0

Triple nickle 2年前

Break 1.81 and it’s boomage imo

👍️0

Triple nickle 2年前

Could break out at 1.68 folks

👍️0

AOuvier 3年前

$VIRX- Took a starter position @ $5.01 today. Partial Order filled

Great to see some upwards strength! GLTA

👍️0

TheSilverFox121 4年前

I just bought in at 9.07 GLTA

don't sell hold on to those shares

stock will jump big today

On February 24, 2021, and in connection with the closing of the merger, Sunesis effected a 1-for-3.5 reverse stock split. All issued and outstanding shares of common stock of Sunesis were subject to the reverse stock split.

👍️0

John_Langston 4年前

What was the RS 1 for 3?

👍️0

Jconwon 4年前

Not even on anyone's radar. 16.25-18. rough 10% with almost no volume. Morning trade is good but hard to really predict these things.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Viracta Therapeutics Inc (VIRX)

個人投資家向けのプロ仕様のツール。

VIRX ニュース

Form 8-K - Current report

Viracta Therapeutics Announces Wind Down of Operations

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

Form 4 - Statement of changes in beneficial ownership of securities

VIRX 財務

VIRX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Viracta Therapeutics Inc (VIRX) ニュース

Viracta Therapeutics Inc (VIRX)

個人投資家向けのプロ仕様のツール。

VIRX ニュース

Form 8-K - Current report

Viracta Therapeutics Announces Wind Down of Operations

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

Form 4 - Statement of changes in beneficial ownership of securities

VIRX 財務

VIRX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

広告を削除する